Atadja, Peter
Novartis Institutes for BioMedical Research,
China
2024 Rank: 165610
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 5447 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 165610 | 175348 |
| Total Cites | 617 | 633 |
| H-index | 11 | 12 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 16 | 16 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 26 | 26 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 69 | 69 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 500 | 514 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.23 |
| Self-Citation Percentage |
2.53%
|
|
Atadja, Peter
Novartis Institutes for BioMedical Research,
China
2023 Rank: 112977
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4023 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 112977 | 132550 |
| Total Cites | 698 | 721 |
| H-index | 12 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 23 | 23 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 32 | 32 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 74 | 74 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 576 | 593 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.22 |
| Self-Citation Percentage |
3.19%
|
|
Atadja, Peter
Novartis Institutes for BioMedical Research,
China
2022 Rank: 88986
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3385 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 88986 | 103077 |
| Total Cites | 742 | 769 |
| H-index | 12 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 30 | 30 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 37 | 37 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 88 | 88 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 613 | 634 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.21 |
| Self-Citation Percentage |
3.51%
|
|
Atadja, Peter
China Novartis Institutes for BioMedical Research,
China
2021 Rank: 84556
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3048 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 84556 | 98492 |
| Total Cites | 1156 | 1199 |
| H-index | 17 | 17 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 36 | 36 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 49 | 50 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 122 | 123 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 926 | 962 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.25 |
| Self-Citation Percentage |
3.59%
|
|
Atadja, Peter
Novartis Institutes for BioMedical Research,
China
2020 Rank: 74823
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2616 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74823 | 81785 |
| Total Cites | 985 | 1036 |
| H-index | 15 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 29 | 29 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 45 | 48 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 90 | 93 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 782 | 819 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.26 |
| Self-Citation Percentage |
4.92%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.